Preparation and method for removing endocrine disrupters in water body
By adding metal borides to the Fe(III)/PAA system, adjusting the pH value of the water body and adding Fe(III) salt, and using B2Mo to activate PAA, the problem of slow regeneration rate of Fe(II) catalyst is solved, and the water body is achieved The efficient removal of endocrine disruptors improves removal rate and is suitable for a variety of pollutants.
Patent Information
- Application Number
- CN202411168944.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-12-03
AI Technical Summary
In the prior art, the regeneration rate of Fe(II) catalyst is extremely slow, limiting the removal effect of the peracetic acid (PAA) system on endocrine disturbances in water bodies. How to improve the catalytic activation ability of Fe(II) has become a research hotspot.
By adjusting the pH value of the water body to no more than 4.0, water-soluble inorganic Fe(III) salt, metal boride and peroxide are added, and the oxidation capacity of the Fe(III)/PAA system is used in concert, and metal borides such as B2Mo are activated by using metal borides such as B2Mo. PAA produces acetylperoxy radicals and hydroxyl radicals, significantly improving the degradation and removal rate of endocrine disruptors.
It significantly improves the removal effect of endocrine disturbances in water. Compared with the use of metal borides or Fe(III) salts and peroxides alone, the removal rate is 85%, and it can achieve efficient degradation at room temperature. The reaction conditions are mild and applicable. It is used in a variety of endocrine disruptors such as bisphenol A, bisphenol S, sulfamethoxazole, etc.
Smart Images

Figure CN119059631A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of sewage treatment, and in particular to a preparation and method for removing endocrine disruptors in water. Background Art
[0002] After being activated, peroxide can generate organic free radicals (CH 3 C(O)OO •- and CH 3 C(O)O •- )and • OH has great potential in degrading pollutants in water. Among them, peracetic acid (PAA) is one of the peroxide oxidants that people have focused on in recent years. The activity of PAA determines the removal effect of endocrine disruptors in water. How to improve the activity of PAA through various physical and chemical means is an effective means to improve the ability of PAA to remove endocrine disruptors in water.
[0003] The PAA activation methods reported so far include ultraviolet light, metal ions (Fe(II), Co(II), Cu(II), Mn(II), and Ru(III)), metal sulfides (FeS, MoS 2 Fe(II) is undoubtedly the most efficient, economical and environmentally friendly catalyst. In theory, it can continuously activate PAA through the redox cycle of iron ions with different valence states. In fact, the regeneration rate of Fe(II) is extremely slow, which becomes the limiting factor for PAA activation. Therefore, how to improve the catalytic activation ability of Fe(II) on the PAA system is the key research direction of the technology related to the removal of endocrine disruptors in water using PAA. Summary of the invention
[0004] The present invention provides a preparation and method for removing endocrine disruptors in water. The preparation and method can enhance the oxidation ability of the Fe(III) / PAA system on endocrine disruptors and expand the application scope of the Fe(III) / PAA system. The present invention is specifically implemented by the following technologies.
[0005] The present invention provides a method for removing endocrine disruptors in water, comprising the following steps: The pH value of the water body to be treated is adjusted to not more than 4.0, and a water-soluble inorganic Fe(III) salt, a metal boride and a peroxide are added, and the treatment is completed after reaction.
[0006] Furthermore, the molar ratio of endocrine disruptors, Fe(III) in water-soluble inorganic Fe(III) salts and peroxides in the water to be treated is 1:(1-16):(2.5-100).
[0007] Furthermore, the molar ratio of endocrine disruptors, Fe(III) in water-soluble inorganic Fe(III) salts and peroxide in the water to be treated is 1:4:10.
[0008] Furthermore, the added concentration of the metal boride is 0.03-0.2 g / L based on the volume of the water to be treated.
[0009] Optionally, the added concentration of the metal boride is 0.1 g / L based on the volume of the water to be treated.
[0010] Furthermore, the reaction time is generally not less than 20 min.
[0011] Furthermore, the metal boride is BMo, B 2 Mo, WB, TiB 2 At least one of .
[0012] It should be noted that any specific selection of the above metal borides can play the same or similar effect of removing endocrine disruptors in water. Any selection of these metal borides falls within the protection scope of the present invention.
[0013] Furthermore, the pH value is adjusted by using an inorganic acid solution and a sodium hydroxide solution.
[0014] Furthermore, the endocrine disruptor is a compound containing a certain structure.
[0015] After extensive research, the present invention has found that the method of the present invention has a very good effect on the degradation and removal of organic compounds with a certain structure. The degradation and removal of these endocrine disruptors all fall within the protection scope of the present invention.
[0016] Furthermore, the endocrine disruptor is at least one of bisphenol A (BPA), bisphenol S (BPS), sulfamethoxazole (SMX), and carbamazepine (CBZ).
[0017] The present invention finds that compared with only using metal borides and peroxides, or using water-soluble inorganic Fe 3+ Salt and peroxide, when metal borides, water-soluble inorganic Fe (III) salts and peroxides are used in conjunction, the degradation and removal effect of endocrine disruptors in water can be significantly improved.
[0018] B 2 Take Mo as an example. After further research, it was found that its working principle is: (1) B 2 The surface oxide of Mo (B 2 O 3 ) first absorbs water to form boric acid (2H 3BO 3 ), the exposed B 2 Mo adsorbs and reduces Fe(III) to produce Fe(II) which is released into the solution. 2 Mo material and Mo 4+ is oxidized to form H 3 BO 3 and Mo 6+ ; (2) In the above step (1) reaction process, 2 Mo generated on the surface of Mo material 6+ It can activate PAA to generate acetyl peroxyl radicals (CH 3 C(O)OO • ), and is reduced to Mo 4+ , complete Mo 6+ / Mo 4+ The redox process generates new Mo 4+ Participate in the reaction process of step (1) above again.
[0019] Fe(III) is oxidized by B 2 Mo is reduced to Fe(II) form, and the generated Fe(II) is continuously consumed for PAA activation.
[0020] The Fe(II) generated in step (1) above can quickly activate PAA to produce acetoxy radicals (CH 3 C(O)O • ) and high-valent iron (Fe(IV)O 2+ ), which can activate the residual H 2 O 2 Formation of hydroxyl radicals ( • OH). After research, it was found that the process of Fe(II) produced by PAA reduction in this process is almost negligible.
[0021] It should be noted that, based on the above-mentioned mechanism of action and related research, the present invention selects water-soluble inorganic Fe(III) salts such as ferric chloride and ferric sulfate, which can exert the same or similar effect of removing endocrine disruptors in water bodies, and these iron salts all fall within the protection scope of the present invention.
[0022] It should be noted that in the above method of the present invention, the method for adjusting the pH value of the water body does not need to be particularly limited. Any method and acid-base regulator that can adjust the pH value to no more than 4.0 can be used in the present invention and belong to the protection scope of the present invention.
[0023] The present invention has been found through research that the method for removing endocrine disruptors in water has very mild reaction conditions and can work at room temperature.
[0024] It should be noted that in the above method provided by the present invention, the peroxide selected can be selected from the group consisting of those capable of generating organic free radicals (CH 3 C(O)OO •- and CH 3 C(O)O •- )and • Any selection of these peroxides belongs to the protection scope of the present invention. Generally, the peroxide of the present invention can be selected from peracetic acid.
[0025] Optionally, the present invention can be adjusted using common water-soluble inorganic acids and inorganic bases.
[0026] Further optionally, the inorganic acid includes but is not limited to dilute hydrochloric acid, dilute sulfuric acid, dilute nitric acid and the like. As long as the acid can be dissolved in water and adjust the pH value of the water body, it belongs to the protection scope of the present invention.
[0027] Further optionally, the inorganic alkali includes but is not limited to alkali solutions such as sodium hydroxide and potassium hydroxide. As long as the alkali can be dissolved in water and adjust the pH value of the water body, it belongs to the protection scope of the present invention.
[0028] The invention also provides a preparation for removing endocrine disruptors in water, comprising a water-soluble inorganic Fe(III) salt, a metal boride and a peroxide.
[0029] Furthermore, the specific amount of the water-soluble inorganic Fe(III) salt, metal boride and peroxide in the above-mentioned preparation depends on the content of endocrine disruptors in the water to be treated.
[0030] Optionally, the molar ratio of the endocrine disruptor, Fe(III) in the water-soluble inorganic Fe(III) salt and the peroxide in the water to be treated is 1:(1-16):(2.5-100), and the added concentration of the metal boride is 0.03-0.2 g / L based on the volume of the water to be treated.
[0031] It is easy to imagine that the raw materials (water-soluble inorganic Fe(III) salts, metal borides and peroxides, etc.) used in the above-mentioned method or preparation for removing endocrine disruptors in water provided by the present invention can be first prepared into reaction mother liquors, and their amounts are appropriately selected and added according to the proportion when used, or the reaction mother liquors are mixed into a mixed liquor in proportion; all solid raw materials can also be placed separately in the preparation tube, and then appropriately selected according to the proportion when used, or all solid raw materials are prepared into a solid mixed preparation in proportion, and then appropriately selected according to the proportion when used. The pre-treatment methods of these raw materials (water-soluble inorganic Fe(III) salts, metal borides and peroxides, etc.) all belong to the protection scope of the present invention.
[0032] Compared with the prior art, the present invention is beneficial in that: 1. The present invention provides a method for removing endocrine disruptors in water, which can more effectively remove endocrine disruptors in water.
[0033] 2. The present invention has a synergistic effect on the removal of endocrine disruptors in water through water-soluble inorganic Fe (III) salts, metal borides and peroxides. Compared with the method of using only metal borides and water-soluble inorganic Fe (III) salts, or only using water-soluble inorganic Fe (III) salts and peroxides, the removal rate of endocrine disruptors in the method of the present invention is increased by 85%. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] Figure 1 This is a comparative experimental diagram of the effects of different formulation systems in removing endocrine disruptors from water.
[0035] In the figure, B 2 Mo means adding only pure B to the water 2 Mo, B 2 Mo / PAA means that only B is added to the water. 2 Mo and PAA, B 2 Mo / Fe(Ⅲ) means adding B to water 2 Mo and water-soluble inorganic Fe(III) salt, Fe(III) / PAA means that only water-soluble inorganic Fe(III) salt and PAA are added to the water body, B 2 Mo / Fe(Ⅲ) / PAA means adding B 2 Mo, water-soluble inorganic Fe(III) salt and PAA.
[0036] Figure 2-4 The preparation system of Example 1 of Test Example 1 was used to remove endocrine disruptors in water before and after the reaction, B 2 Mo micromorphology and structure (SEM) diagram, X-ray diffraction spectrum (XRD) diagram and X-ray photoelectron spectrum (XPS) diagram.
[0037] Figure 5 Preparation system B of Example 1 of Test Example 1 2 Mo / Fe(III) / PAA, removal efficiency of endocrine disruptors in water as a function of initial pH value.
[0038] Figure 6 Preparation system B of Example 1 of Test Example 1 2 Mo / Fe(III) / PAA, removal efficiency of endocrine disruptors from water affected by anions and humic acid.
[0039] Figure 7 Preparation system B of Example 1 of Test Example 1 2 Mo / Fe(III) / PAA, removal efficiency of endocrine disruptors from water affected by endocrine disruptors, water-soluble inorganic Fe(III) salts, metal borides and peroxides. DETAILED DESCRIPTION
[0041] The technical solution of the present invention will be described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0042] In some embodiments of the present invention, a method for removing endocrine disruptors in water is provided, comprising the following steps: The pH value of the water body to be treated is adjusted to not more than 4.0, and a water-soluble inorganic Fe(III) salt, a metal boride and a peroxide are added, and the treatment is completed after reaction.
[0043] By using metal borides, water-soluble inorganic Fe(III) salts and peroxides in a coordinated manner, the degradation and removal effect of endocrine disruptors in water can be significantly improved.
[0044] B 2 Take Mo as an example. After further research, it was found that its working principle is: (1) B 2 The surface oxide of Mo (B 2 O 3 ) first absorbs water to form boric acid (2H 3 BO 3 ), the exposed B 2 Mo adsorbs and reduces Fe(III) to produce Fe(II) which is released into the solution. 2 Mo material and Mo 4+ is oxidized to form H 3 BO 3 and Mo 6+ ; (2) In the above step (1) reaction process, 2 Mo generated on the surface of Mo material 6+ It can activate PAA to generate acetyl peroxyl radicals (CH 3 C(O)OO • ), and is reduced to Mo 4+ , complete Mo 6+ / Mo 4+ The redox process generates new Mo4+ It participates in the reaction process of step (1) again; while Fe(III) is 2 Mo is reduced to Fe 2+ Form, generated Fe 2+ It is continuously consumed for PAA activation.
[0045] The Fe(II) generated in step (1) above can quickly activate PAA to produce acetoxy radicals (CH 3 C(O)O • ) and high-valent iron (Fe(IV)O 2+ ), which can activate the residual H 2 O 2 Formation of hydroxyl radicals ( • OH). After research, it was found that the process of F(II) produced by PAA reduction can be almost ignored.
[0046] It should be noted that, based on the above-mentioned mechanism of action and related research, the present invention selects water-soluble inorganic Fe(III) salts such as ferric chloride and ferric sulfate, which can exert the same or similar effect of removing endocrine disruptors in water bodies, and these iron salts all fall within the protection scope of the present invention.
[0047] In some embodiments of the present invention, when removing endocrine disruptors from water, the method for adjusting the pH value of the water body does not need to be particularly limited. Any method and acid-base regulator that can adjust the pH value to no more than 4.0 can be used in the present invention and fall within the scope of protection of the present invention.
[0048] In some embodiments of the present invention, the present invention can optionally use common water-soluble inorganic acids and inorganic bases for adjustment. As long as the acid or base can be dissolved in water and adjust the pH value of the water body, it belongs to the protection scope of the present invention.
[0049] Typically, the pH can be adjusted to 2.0, 2.5, 2.8, 3.0, 3.2, 3.5 or 4.0.
[0050] Further optionally, the inorganic acid includes but is not limited to dilute hydrochloric acid, dilute sulfuric acid, dilute nitric acid and the like.
[0051] Further optionally, the inorganic base includes but is not limited to alkali solutions such as sodium hydroxide and potassium hydroxide.
[0052] In some embodiments of the present invention, the peroxide selected can be selected from the group consisting of those capable of generating organic free radicals (CH 3 C(O)OO •- and CH 3 C(O)O •- )and •Any selection of these peroxides belongs to the protection scope of the present invention.
[0053] Optionally, the peroxide selected is peracetic acid.
[0054] In some embodiments of the present invention, the concentration ratio of endocrine disruptors, Fe(III) in water-soluble inorganic Fe(III) salts, and peroxides in the water to be treated is 1:(1-16):(2.5-100)).
[0055] Optionally, the concentration ratio of endocrine disruptors, Fe(III) in water-soluble inorganic Fe(III) salts and peroxides in the water to be treated is 1:4:10.
[0056] Optionally, the added concentration of the metal boride is 0.03-0.2 g / L based on the volume of the water to be treated.
[0057] Optionally, the added concentration of the metal boride is 0.1 g / L based on the volume of the water to be treated.
[0058] In some implementation cases of the present invention, the reaction time for removing endocrine disruptors in water is not less than 20 minutes.
[0059] In some embodiments of the present invention, any specific selection of metal borides can achieve the same or similar effect of removing endocrine disruptors in water and fall within the protection scope of the present invention.
[0060] In other embodiments of the present invention, the metal boride is BMo, B 2 Mo, WB, TiB 2 At least one of .
[0061] In other embodiments of the present invention, the endocrine disruptor is a compound containing a certain structure.
[0062] After extensive research, the present invention has found that the method of the present invention has a very good effect on the degradation and removal of organic compounds with a certain structure. The degradation and removal of these endocrine disruptors all fall within the protection scope of the present invention.
[0063] Furthermore, the endocrine disruptor is at least one of bisphenol A (BPA), bisphenol S (BPS), sulfamethoxazole (SMX), and carbamazepine (CBZ).
[0064] The invention also provides a preparation for removing endocrine disruptors in water, comprising a water-soluble inorganic Fe(III) salt, a metal boride and a peroxide.
[0065] The specific amount of water-soluble inorganic Fe(III) salt, metal boride and peroxide in the above preparation depends on the content of endocrine disruptors in the water to be treated.
[0066] Optionally, the molar ratio of the endocrine disruptor, Fe(III) in the water-soluble inorganic Fe(III) salt and the peroxide in the water to be treated is 1:(1-16):(2.5-100), and the added concentration of the metal boride is 0.03-0.2 g / L based on the volume of the water to be treated.
[0067] In the following specific implementations, the water to be treated is prepared by adding BPA to deionized water, and the BPA concentration is 10 μM. This is used as the water sample to be treated.
[0068] Example 1: Comparison of the removal effects of different formulation systems on endocrine disruptors in water The preparation for removing endocrine disruptors in water provided in this test example includes a water-soluble inorganic Fe(III) salt, a metal boride and a peroxide, wherein the water-soluble inorganic Fe(III) salt is Fe 2 (SO 4 ) 3 , metal boride is B 2 Mo, and the peroxide is peracetic acid (PAA). The amounts of endocrine disruptor BPA, water-soluble inorganic Fe(III) salts, metal borides, and peroxides in water are shown in Table 1 below.
[0069] Table 1 Ratio of raw materials used in preparations for removing endocrine disruptors from water
[0070] The method for removing the endocrine disruptor bisphenol A (BPA) in the water body to be tested by using the preparations prepared in the above examples and comparative examples is as follows: (1) Take 100 ml of the water to be treated and add it to a 250 ml glass beaker. Place a heat-collecting constant temperature heating magnetic stirrer in the beaker for constant temperature water bath and magnetic stirring. The constant temperature of the water bath is set at 25°C. (2) Use 1.0M H 2 SO 4 solution and 0.1M NaOH solution to adjust the pH value of the water to be treated to about 2.0; (3) Fe 2 (SO 4 ) 3 , B 2 Mo and peracetic acid PAA were added to the water to be treated according to the ratio in Table 1, and the timing was started, and the mixture was stirred at room temperature for 20 min.
[0071] Add excess Na into the liquid phase bottle 2 SO 3 The solution was used as a terminator. After a certain period of time, the reaction solution was taken and filtered using a 0.22 μm filter membrane and then transferred to a liquid phase bottle for testing. In order to ensure the reliability of the experimental data, all experiments were performed at least twice and the standard deviation was calculated.
[0072] The experimental results of the formulation systems of Example 1 and Comparative Examples 1-4 are as follows Figure 1 shown. Figure 1 Shows B 2 Single factor control experimental results of Mo / Fe(III) / PAA system.
[0073] from Figure 1 As you can see, B 2 Mo / BPA (without Fe 2 (SO 4 ) 3 The concentration of BPA in the adsorption / desorption-time curves of BPA and PAA remained above 95%, indicating that 2 The adsorption of Mo on BPA is weak.
[0074] When Fe(III) (without PAA) coexists in the solution, B 2 There was no significant change in the BPA concentration in the Mo / Fe(III) system, proving that Fe(III) did not affect BPA 2 Adsorption performance of Mo on BPA. The removal rate of BPA in the Fe(III) / PAA system is still low (about 10%). This may be due to the weak activation effect of Fe(III) on peroxides including PAA.
[0075] In B 2 Mo / PAA system (without Fe 2 (SO 4 ) 3 ) curve, and B 2 The Mo / BPA curves overlap, proving that B 2 Mo cannot activate PAA directly.
[0076] In B 2 In the Mo / Fe(III) / PAA system, B 2 The coexistence of Mo and Fe(III) increased the BPA removal rate by about 85%, which indicates that the B 2 The Mo / Fe(III) / PAA system exhibits excellent performance in efficiently removing BPA.
[0077] Example 2: B before and after the reaction using the formulation system of Example 1 2 Mo characterization In the reaction of removing endocrine disruptors from water using the formulation system provided in Example 1, Mo 4+ and Mo 6+ Cyclic production and consumption, Fe(II) and Fe(III) are also cyclically produced and consumed.
[0078] 1. SEM test Figure 2 Before the reaction in this Example 1 ( Figure 2 a and Figure 2 b) and after reaction ( Figure 2 c and Figure 2 d) In the formulation system, B 2 SEM image of Mo. Figure 2 a and Figure 2 c is 10,000 times magnification, Figure 2 b and Figure 2 d is a SEM image magnified 100,000 times. It can be seen that B before the reaction 2 The Mo material is in a discrete form as a whole, consisting of a disordered block-like gravel structure. The sharp edges and broken state of the gravel structure can be clearly seen in the 100,000x image. 2 The Mo sample has no significant changes in overall structure and composition. It can be seen that the preparation system of the present invention can be repeatedly reused, and the removal effect of endocrine disruptors in water remains relatively stable, with good reproducible effect.
[0079] 2. XRD test Figure 3 B before and after the reaction of this embodiment 1 2 Mo X-ray diffraction spectrum (XRD) diagram. It can be seen that there is no obvious difference in the diffraction peaks of the sample of the formulation system before and after use and there are no other impurity peaks. This indicates that B 2 The Mo sample has high crystallinity, and the diffraction peaks at 25.5°, 34.6°, 35.4°, 40.7°, 46.1°, 49.2°, and 67.7° are similar to those of MoB. 5 The diffraction peaks at (006), (101), (102), (015), (107), (108) and (110) crystal planes (JCPS No.38-1460) are highly consistent, proving that the formulation system provided by the present invention can be reused and has good reproducibility.
[0080] 3. XPS test
[0081] Figure 4 B before and after the reaction of this embodiment 1 2 X-ray photoelectron spectroscopy (XPS) of Mo. Figure 4 a can be seen, before and after the reaction B 2The XPS spectrum of Mo shows almost no change, and contains elements such as Mo, O, and B. Although the B content is very high, the intensity of the B1s peak in the XPS spectrum is very low, which may be due to its low sensitivity. 2 No Fe element signal was detected in Mo, which may be due to the low Fe content on the surface of the material. This is consistent with the Fe mass ratio of less than 8% in the EDS results.
[0082] In the O1s high-resolution XPS spectrum ( Figure 4 b), the peak at 530.91 eV belongs to the lattice oxygen of O1s, and the peak at 531.72 eV matches the adsorbed oxygen. 2 The lattice oxygen intensity of Mo's O1s is slightly enhanced.
[0083] Although the intensity of the B1s peak is slightly lower, it can be seen that there are characteristic peaks at 188.19 eV, 189.14 eV, and 192.28 eV, corresponding to the BO bond, B-Mo bond, and BB bond, respectively ( Figure 4 c). Figure 4 Compared with O1s of b, after reaction B 2 The strength of the B-Mo and BB bonds of Mo increases more significantly, while the strength of the BO bond decreases. This may be because B 2 The surface of Mo is covered by boron oxide, and the deep B 2 Mo.
[0084] Figure 4 d is Mo 3 d high-resolution spectrum, according to the "Handbook of X-ray Photoelectron Spectroscopy" combined with relevant literature on molybdenum boride materials to confirm that B 2 Mo's Mo 3 d corresponds to three valence states, namely Mo 0 、Mo 3+ and Mo 4+ ; In the spectrum after the reaction, it originally belonged to Mo 3+ The peak of Mo disappeared and appeared 6+ The peak corresponding to Mo 0 and Mo 4+ The peak of the 2 Mo, on the other hand, may be due to the molybdenum ion promoting the Fe(III) / Fe(II) redox cycle process, because B alone 2 The reason why Mo cannot directly activate PAA is B 2 Mo cannot expose Mo by capturing protons under acidic conditions. 4+ active site.
[0085] Example 3: Effect of the initial pH value of the water to be treated on the effect of the formulation system on the removal of endocrine disruptors in the water This test example is used to compare the effect of the initial pH value of the water body to be treated on the removal effect of endocrine disruptors in the water body. The initial pH value of the water body to be treated was decomposed and adjusted to 2.0, 2.5, 2.8, 3.0, 3.2, 3.5, 4.0, 5.0, 6.0 and 7.0 respectively, and the other steps were consistent with those of Test Example 1. Figure 5 B provided by Example 1 of Experimental Example 1 2 Mo / Fe(III) / PAA system, removal rate changes with initial value when removing endocrine disruptors from water.
[0086] from Figure 5 a It can be seen that when the initial pH is 2.0-4.0, the B provided in Example 1 2 After 20 minutes of reaction in the Mo / Fe(III) / PAA system, BPA in the system can be efficiently degraded; when the initial pH value exceeds 4.0, the final removal rate of BPA will rapidly decrease to about 20%.
[0087] from Figure 5 b It can be seen that when the initial pH value is 2.0-4.0, consistent with the trend of the degradation rate of BPA, the decomposition rate of PAA also continues to slow down. It is worth noting that all PAA is completely consumed.
[0088] In the formulation system provided by the present invention, the iron exists in the form of Fe(III), Fe(II) and Fe(IV), and is finally all converted to B 2 Mo is reduced to Fe(II) form.
[0089] Figure 5 c is the curve of Fe(II) concentration changing with the initial pH. It can be seen that when the initial pH is ≤2.8, the accumulation rate of Fe(II) is faster. 2 O) 2+ and Fe(II) • Under the combined influence of the quenching effect of OH. When the initial pH is 2.8, B 2 Mo / Fe(III) / PAA has the fastest accumulation rate. When the initial pH is ≥3.0, Fe(III) in the solution begins to hydrolyze and the degree of hydrolysis increases with the increase of pH. Fe(II) and Fe(III) form various complexes including FeOH + , Fe(OH) 2 , FeOH 2+ , Fe 2 (OH) 24+ , Fe(OH) 2 + , Fe(OH) 3 and Fe(OH) 4 - , which is not conducive to the degradation of BPA. The formed iron hydroxide precipitation leads to a decrease in the total iron content in the solution, so the final Fe(II) concentration is also reduced. When the initial pH is 4.0, there is less than 20 μM in the solution.
[0090] Phenyl sulfone (PMSO 2 ) is a characteristic product formed by the oxidation of methyl phenyl sulfoxide (PMSO) by Fe(IV), which is similar to PMSO. • OH, SO 4 •- There are obvious differences in the oxidation products of active substances such as PMSO. Therefore, in this example, PMSO is selected as a molecular probe, and high performance liquid chromatography is used for qualitative and semi-quantitative analysis of Fe(IV) in the system. The specific detection method is: use 100 µM PMSO to replace BPA in the solution, and the other experimental steps are the same as the degradation experiment. The experimental parameters are set as follows: the liquid phase ultraviolet detection wavelength is 215nm, the injection volume is 30 μL, the mobile phase is acetonitrile and pure water, the volume ratio of the two is 30:70, the flow rate is set to 1.0 mL / min, the column temperature is maintained at 30°C, and PMSO and PMSO are recorded. 2 The peak area was used to calculate the conversion efficiency.
[0091] Figure 5 d is the decomposition of PMSO and PMSO in the solution at different initial pH values 2 The curve is generated. It can be seen that when the initial pH is 2.0-3.5, Fe(IV) is in PMSO / PMSO 2 When the initial pH was 4.0, the relative contribution of Fe(IV) decreased, which was attributed to the instability of Fe(IV) under high pH conditions.
[0092] Example 4: Effects of anions and humic acid (HA) on the removal of endocrine disruptors from water by the formulation system The method of this test example is: (1) Take 100 ml of the water to be treated and add it to a 250 ml glass beaker. Place a heat-collecting constant temperature heating magnetic stirrer in the beaker for constant temperature water bath and magnetic stirring. The constant temperature of the water bath is set at 25°C. (2) Use 1.0 M H 2 SO 4 solution and 0.1 M NaOH solution to adjust the pH value of the water to be treated to 2.8; (3) Add 5.0 M anion (SO4 2- 、NO 3 - or Cl - ) and humic acid (HA) solution were added to the water to be treated in proportion so that the three anions or humic acid (HA) reached 10, 20 and 50 mM, respectively, i.e., a total of 12 groups of experiments; (4) Fe 2 (SO 4 ) 3 , B 2 Mo and peracetic acid (PAA) were added to the water to be treated according to the ratio in Table 1, and the timing was started, and the mixture was stirred at room temperature for 20 min.
[0093] Using B provided in Example 1 of Test Example 1 2 The removal rate of endocrine disruptors in water by Mo / Fe(III) / PAA system is affected by anions and humic acid. Figure 6 As shown. Figure 6 As shown in a-6c, when the concentration of inorganic anions is 10 mM, the degradation rate of BPA is inhibited to a certain extent. This may be because inorganic anions will react with • OH and R-O • The reaction formed some weak oxidative active substances. When the concentration of inorganic anions was further increased to 20 and 50 mM, the corresponding inhibitory effect was not further significantly enhanced. This indicates that inorganic anions have an inhibitory effect on B 2 The effect of Mo / Fe(III) / PAA system on removing BPA is limited.
[0094] like Figure 6 As shown in d, due to the HA • OH and R−O • It has strong scavenging ability, so it has strong 2 The effect on BPA degradation was more obvious in the Mo / Fe(III) / PAA system. When the HA dosage was increased to 50 mg / L, the degradation process of BPA was more significantly inhibited, and the corresponding removal rate was reduced to 60%.
[0095] Example 5: Effect of the content of endocrine disruptors in water, the dosage of water-soluble inorganic Fe(III) salts, metal borides and peroxides on the removal of endocrine disruptors in water The same method for removing endocrine disruptors from water was used and adjusted as follows: (1) Adjust the reaction system to 2 The initial concentrations of Mo were 0, 0.03, 0.05, 0.1 and 0.2 g / L respectively; (2) the Fe 2 (SO 4 )3 The initial concentrations of PAA in the reaction system were 0, 20, 40, 60 and 80 μM, respectively; (3) the initial concentrations of PAA in the reaction system were adjusted to 0, 0.05, 0.1, 0.2 and 0.5 mM, respectively; (4) the initial concentrations of endocrine disruptors in the water body were adjusted to 5, 10, 15 and 20 μM, respectively. The removal effects of endocrine disruptors in water bodies were verified respectively.
[0096] like Figure 7 a-7d, respectively, for different dosages of B 2 Mo, Fe(III), PAA and BPA.
[0097] from Figure 7 a and 7b can be seen that as B 2 The removal rate of BPA increased significantly with the increase of Mo and Fe(III) dosage. 2 Both Mo and Fe(III) can accelerate the Fe(II) regeneration process. 2 When the Mo dosage reached 0.1 g / L, the degradation rate of BPA slowed down. Similarly, the effect of Fe(III) dosage exceeding 40 μM on BPA degradation became smaller and smaller, indicating that Fe(III) was no longer a limiting factor. 2 The upper limit of Mo or Fe(III) dosage is 0.1 g / L and 40 μM.
[0098] from Figure 7 c It can be seen that the BPA degradation rate did not decrease after reaching the maximum value by continuously increasing the PAA dosage in the target system. This is because B 2 The reduction rate of Mo to Fe(III) is very fast, so excessive PAA will be continuously decomposed by the generated Fe(II), and a PAA concentration of 0.1 mM is more economical.
[0099] from Figure 7 d It can be seen that when the other reaction conditions are fixed, the active substances produced in the solution are limited. Therefore, the ratio of BPA removed at the same time to the initial BPA concentration continues to decrease as the initial BPA concentration continues to increase.
[0100] The above specific embodiments describe the implementation of the present invention in detail, but the present invention is not limited to the specific details in the above embodiments. Within the scope of the claims and technical concept of the present invention, the technical solution of the present invention can be modified and changed in many simple ways, and these simple modifications all belong to the protection scope of the present invention.
Claims
1. A method for removing endocrine disruptors in water, characterized in that: The following steps are involved: The pH value of the water body to be treated is adjusted to not more than 4.0, and a water-soluble inorganic Fe(III) salt, a metal boride and a peroxide are added, and the treatment is completed after reaction.
2. The method for removing endocrine disruptors in water according to claim 1, characterized in that: The molar ratio of endocrine disruptors, Fe(III) in water-soluble inorganic Fe(III) salts and peroxides in the water to be treated is 1:(1-16):(2.5-100).
3. The method for removing endocrine disruptors in water according to claim 2, characterized in that: The molar ratio of endocrine disruptors, Fe(III) in water-soluble inorganic Fe(III) salt and peroxide in the water to be treated is 1:4:
10.
4. The method for removing endocrine disruptors in water according to claim 2, characterized in that: The added concentration of the metal boride is 0.03-0.2 g / L based on the volume of the water to be treated.
5. The method for removing endocrine disruptors in water according to claim 1, characterized in that: The metal boride is at least one of BMo, B2Mo, WB, and TiB2.
6. The method for removing endocrine disruptors in water according to claim 1, characterized in that: The pH value is adjusted by using an inorganic acid solution and a sodium hydroxide solution, wherein the acid radical ions of the inorganic acid solution correspond to the acid radical ions of the water-soluble inorganic Fe(III) salt.
7. The method for removing endocrine disruptors in water according to claim 1, characterized in that: The endocrine disruptor is at least one of bisphenol A, bisphenol S, sulfamethoxazole and carbamazepine.
8. A preparation for removing endocrine disruptors in water, characterized in that: The method comprises a water-soluble inorganic Fe(III) salt, a metal boride and a peroxide. The molar ratio of the endocrine disruptor in the water to be treated, the Fe(III) in the water-soluble inorganic Fe(III) salt and the peroxide is 1:(1-16):(2.5-100). The added concentration of the metal boride is 0.03-0.2 g / L based on the volume of the water to be treated.
Citation Information
Patent Citations
Method for removing endocrine disrupting substance remained in water based on catalysis of persulfate by boron-and-neodymium-modified sillenite bismuth ferrite
CN108640249A
Agent and method for removing organic pollutants in water and application
CN113979530A
Method for treating organic wastewater by activating peracetic acid with assistance of amorphous boron
CN114656026A
Preparation method of catalyst for removing endocrine disrupter, catalyst and application of catalyst
CN114950428A
